Exploring hidden risk: The prevalence of humoral immunodeficiency in patients with lymphoproliferative disorders—A prospective study

Authors

Hassan Saeed, Rochester Regional HealthFollow
Syed Usman Mohsin Ehsanullah, Rochester Regional HealthFollow
Mouna Reghis, Rochester Regional HealthFollow
Mariam A.O. Mostafa, Rochester Regional HealthFollow
Jonathan Bress, Rochester Regional HealthFollow
S Shahzad Mustafa, Rochester Regional HealthFollow
Saad Jamshed, Rochester Regional HealthFollow

Department

Medicine

Additional Department

Oncology and Hematology

Document Type

Conference Proceeding

Publication Title

Journal of Clinical Oncology

Conference Name

American Society of Clinical Oncology (ASCO) Annual Meeting

Conference Date

2025-05-30 - 2025-06-03

First Page

e19083

DOI

10.1200/JCO.2025.43.16_suppl.e19083

Volume

43

Issue

16_suppl

Publication Date

6-1-2025

Recommended Citation

Saeed, H., Ehsanullah, S. M., Reghis, M., Mostafa, M. A., Bress, J., Mustafa, S. S., & Jamshed, S. (2025). Exploring hidden risk: The prevalence of humoral immunodeficiency in patients with lymphoproliferative disorders—A prospective study. Journal of Clinical Oncology, 43 (16_suppl), e19083. https://doi.org/10.1200/JCO.2025.43.16_suppl.e19083